Home LiteratureArticle Details
PMID: 22531301 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Etiology of autistic features: the persisting neurotoxic effects of propionic acid.

Journal of neuroinflammation ·Vol. 9 ·2012-04-24 ·Pages 74

El-Ansary AK, Ben Bacha A, Kotb M

Abstract

Recent clinical observations suggest that certain gut and dietary factors may transiently worsen symptoms in autism. Propionic acid (PA) is a short chain fatty acid and an important intermediate of cellular metabolism. Although PA has several beneficial biological effects, its accumulation is neurotoxic. Two groups of young Western albino male rats weighing about 45 to 60 grams (approximately 21 days old) were used in the present study. The first group consisted of oral buffered PA-treated rats that were given a neurotoxic dose of 250 mg/kg body weight/day for three days, n = eight; the second group of rats were given only phosphate buffered saline and used as a control. Biochemical parameters representing oxidative stress, energy metabolism, neuroinflammation, neurotransmission, and apoptosis were investigated in brain homogenates of both groups. Biochemical analyses of brain homogenates from PA-treated rats showed an increase in oxidative stress markers (for example, lipid peroxidation), coupled with a decrease in glutathione (GSH) and glutathione peroxidase (GPX) and catalase activities. Impaired energy metabolism was ascertained through the decrease of lactate dehydrogenase and activation of creatine kinase (CK). Elevated IL-6, TNFα, IFNγ and heat shock protein 70 (HSP70) confirmed the neuroinflammatory effect of PA. Moreover, elevation of caspase3 and DNA fragmentation proved the pro-apoptotic and neurotoxic effect of PA to rat pups By comparing the results obtained with those from animal models of autism or with clinical data on the biochemical profile of autistic patients, this study showed that the neurotoxicity of PA as an environmental factor could play a central role in the etiology of autistic biochemical features.

MeSH Terms
Animals Autistic Disorder/chemically induced,physiopathology Brain/drug effects,metabolism Disease Models, Animal Male Oxidative Stress/drug effects,physiology Propionates/metabolism,toxicity Random Allocation Rats
Chemicals
Propionates propionic acid
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
El-Ansary Afaf K
Biochemistry Department, Science College, King Saud University, Riyadh, Saudi Arabia. afafelansary@yahoo.com
Ben Bacha Abir
Kotb Malak
References (53)
53 references, click to expand
  1. Midbrain serotonergic neurons are central pH chemoreceptors.
    Nat Neurosci. 2003 Nov;6(11):1139-40 PMID: 14517544
  2. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress.
    Brain Pathol. 2005 Apr;15(2):159-66 PMID: 15912889
  3. Essential polyunsaturated fatty acids and social cognition in schizophrenia.
    Psychiatry Res. 2008 Jan 15;157(1-3):87-93 PMID: 17976738
  4. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism.
    Pediatr Res. 2002 Oct;52(4):576-9 PMID: 12357053
  5. A new colorimetric technique for the estimation of vitamin C using Folin phenol reagent.
    Anal Biochem. 1982 Nov 15;127(1):178-82 PMID: 7165085
  6. Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal.
    Folia Neuropathol. 2010;48(4):258-69 PMID: 21225508
  7. Investigation of antioxidant enzymes in children with autistic disorder.
    Prostaglandins Leukot Essent Fatty Acids. 2002 Nov;67(5):341-3 PMID: 12445495
  8. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders.
    Behav Brain Res. 2007 Jan 10;176(1):149-69 PMID: 16950524
  9. Dystrophic serotonin axons in postmortem brains from young autism patients.
    Anat Rec (Hoboken). 2011 Oct;294(10):1653-62 PMID: 21901837
  10. Elevated immune response in the brain of autistic patients.
    J Neuroimmunol. 2009 Feb 15;207(1-2):111-6 PMID: 19157572
  11. Omega-3 fatty acids and neuropsychiatric disorders.
    Reprod Nutr Dev. 2005 Jan-Feb;45(1):1-28 PMID: 15865053
  12. Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders.
    Int Clin Psychopharmacol. 2006 Nov;21(6):319-36 PMID: 17012979
  13. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia.
    Biol Psychiatry. 2000 Jan 1;47(1):8-21 PMID: 10650444
  14. Blood-brain barrier disruption, HSP70 expression and apoptosis due to 3-nitropropionic acid, a mitochondrial toxin.
    Acta Neurochir Suppl. 1997;70:237-9 PMID: 9416333
  15. Metabolic biomarkers related to energy metabolism in Saudi autistic children.
    Clin Biochem. 2009 Jul;42(10-11):949-57 PMID: 19376103
  16. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies.
    J Inherit Metab Dis. 2004;27(4):427-48 PMID: 15303000
  17. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism.
    Eur Arch Psychiatry Clin Neurosci. 2004 Jun;254(3):143-7 PMID: 15205966
  18. Characterization of alpha-keto acid transport across blood-brain barrier in rats.
    Am J Physiol. 1983 Sep;245(3):E253-60 PMID: 6614164
  19. Oxidative stress in autism.
    Pathophysiology. 2006 Aug;13(3):171-81 PMID: 16766163
  20. Dopamine-beta-hydroxylase (DBH) and homovanillic acid (HVA) in autistic children.
    J Autism Dev Disord. 1986 Mar;16(1):23-9 PMID: 3957856
  21. Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells.
    Neuroscience. 2009 Dec 29;164(4):1744-53 PMID: 19788916
  22. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.
    J Lab Clin Med. 1967 Jul;70(1):158-69 PMID: 6066618
  23. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.
    Brain Behav Immun. 2011 Jan;25(1):40-5 PMID: 20705131
  24. Autistic disorder and phospholipids: A review.
    Prostaglandins Leukot Essent Fatty Acids. 2011 Jan-Feb;84(1-2):25-30 PMID: 20970971
  25. [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions.
    Neurochem Int. 2003 Jul;43(1):9-17 PMID: 12605878
  26. Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment.
    Br J Cancer. 1993 Dec;68(6):1080-7 PMID: 8260358
  27. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation.
    Ann Neurol. 2001 May;49(5):597-606 PMID: 11357950
  28. Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management.
    Eur J Pharmacol. 2011 Sep;668 Suppl 1:S70-80 PMID: 21810417
  29. A simple method for the isolation and purification of total lipides from animal tissues.
    J Biol Chem. 1957 May;226(1):497-509 PMID: 13428781
  30. Fatty acid transport into the brain: of fatty acid fables and lipid tails.
    Prostaglandins Leukot Essent Fatty Acids. 2011 Nov;85(5):293-302 PMID: 21816594
  31. Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3-neurones.
    Eur Neuropsychopharmacol. 2000 Mar;10(2):97-103 PMID: 10706990
  32. Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats.
    Behav Brain Res. 2012 Feb 1;227(1):134-41 PMID: 22085877
  33. Cerebrospinal fluid and serum markers of inflammation in autism.
    Pediatr Neurol. 2005 Sep;33(3):195-201 PMID: 16139734
  34. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes.
    Steroids. 1994 Jun;59(6):383-8 PMID: 7940617
  35. Animal models of autism spectrum disorders: information for neurotoxicologists.
    Neurotoxicology. 2009 Sep;30(5):811-21 PMID: 19596370
  36. Commentary: the acquisition and use of human brain tissue in neuropsychiatric research.
    Schizophr Bull. 1991;17(4):593-6 PMID: 1805352
  37. Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia.
    J Neuroinflammation. 2011 Oct 15;8:142 PMID: 21999440
  38. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism.
    Neuropharmacology. 2008 May;54(6):901-11 PMID: 18395759
  39. Maintenance of lipid asymmetry in red blood cells and ghosts: effect of divalent cations and serum albumin on the transbilayer distribution of phosphatidylserine.
    Biochim Biophys Acta. 1990 Jun 11;1025(1):82-6 PMID: 2369579
  40. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia.
    Lipids Health Dis. 2011 Apr 22;10:63 PMID: 21513514
  41. Neuroglial activation and neuroinflammation in the brain of patients with autism.
    Ann Neurol. 2005 Jan;57(1):67-81 PMID: 15546155
  42. Improved method for the determination of blood glutathione.
    J Lab Clin Med. 1963 May;61:882-8 PMID: 13967893
  43. Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia.
    Lipids Health Dis. 2011 Apr 21;10:62 PMID: 21510882
  44. Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors.
    Neuropharmacology. 2011 Jun;60(7-8):1347-54 PMID: 21329710
  45. Dopamine and serotonin levels following prenatal viral infection in mouse--implications for psychiatric disorders such as schizophrenia and autism.
    Eur Neuropsychopharmacol. 2008 Oct;18(10):712-6 PMID: 18693086
  46. Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism.
    Brain Res. 2011 Mar 22;1380:218-28 PMID: 20858465
  47. L-2-Chloropropionic acid metabolism and disposition in male rats: relevance to cerebellar injury.
    Arch Toxicol. 1997;71(11):668-76 PMID: 9363839
  48. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism.
    J Neurochem. 2011 Apr;117(2):209-20 PMID: 21250997
  49. Clinical and biochemical approach to the neonate with a suspected inborn error of amino acid and organic acid metabolism.
    Semin Perinatol. 1999 Apr;23(2):162-73 PMID: 10331467
  50. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children.
    Clin Biochem. 2009 Jul;42(10-11):1032-40 PMID: 19306862
  51. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: Relevance to autism spectrum disorder.
    Behav Brain Res. 2011 Feb 2;217(1):47-54 PMID: 20937326
  52. Identifying environmental contributions to autism: provocative clues and false leads.
    Ment Retard Dev Disabil Res Rev. 2004;10(4):292-302 PMID: 15666339
  53. Essential fatty acids and the brain.
    Can J Psychiatry. 2003 Apr;48(3):195-203 PMID: 12728744
Article Info
Journal
Journal of neuroinflammation
Abbr.
J Neuroinflammation
ISSN
1742-2094
Published
2012-04-24
Epub
2012-00-24
Pages
74
Language
English
Region
England
NLM ID
101222974
PMCID
PMC3425128
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com